Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation

NANot yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Varus-Derotation Osteotomy SurgeryIron-deficiency AnemiaPelvic Osteotomy SurgeryCerebral Palsy
Interventions
DIETARY_SUPPLEMENT

Iron Supplement

FeraMAX Pd powder 15: NPN 80109337 FeraMAX Pd Therapeutic 150 capsules: NPN 80075623 (for an adolescent that can swallow capsules)

DIETARY_SUPPLEMENT

Comprehensive Nutrition Management

Standard nutrition care will depend on the results of the nutrition assessment, as well as underlying conditions, and will be performed regardless of iron supplementation. The intervention will be at the discretion of the dietician but may include; diet education, recommendations for vitamin and mineral supplements, optimization of tube feeds (if the child is tube fed), high protein or high energy diet education if the child is underweight, dddition of oral nutrition supplements (i.e., Pediasure or Ensure) to promote weight gain in orally fed children, discussion surrounding enteral feeding (for children who are orally fed, but severely malnourished and cannot meet their nutritional needs by mouth).

Trial Locations (1)

V6H 3N1

BC Children's Hospital, Vancouver

All Listed Sponsors
collaborator

BC Children's Hospital Research Institute

OTHER

lead

University of British Columbia

OTHER

NCT07095244 - Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation | Biotech Hunter | Biotech Hunter